SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 17, 2000
OAK TREE MEDICAL SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
<TABLE>
<CAPTION>
<S> <C> <C> <C>
Delaware 0-16206 02-0401674
(State or other jurisdiction of (Commission file number) (I.R.S. employer
incorporation or organization) identification no.)
1725 Tenbroeck Avenue
Bronx, New York 10461
(Address of principal executive offices) (Zip code)
</TABLE>
Registrant's telephone number, including area code: (718) 828-6996
<PAGE>
Item 4. Changes in Registrant's Certifying Accountant
(a) Previous independent accountants
On August 17, 2000, Oak Tree Medical Systems, Inc. (the "Company")
dismissed Grant Thornton LLP ("Grant Thornton") as the independent accountants
for the Company. Grant Thornton's report on the financial statements of the
Company for the fiscal year ended May 31, 1999 did not contain an adverse
opinion or disclaimer of opinion, and was not qualified or modified as to
uncertainty, audit scope or accounting principles. During the Company's fiscal
year ended May 31, 1999 and through August 17, 2000, there were no disagreements
between the Company and Grant Thornton on any matter of accounting principles or
practices, financial statement disclosure, or auditing scope or procedure, which
disagreements, if not resolved to the satisfaction of Grant Thornton, would have
caused it to make reference to the subject matter of the disagreements in
connection with its report. During the Company's fiscal year ended May 31, 1999
and through August 17, 2000, Grant Thornton did not advise the Company of any of
the matters referred to in Item 304(a)(1)(iv)(B) of Regulation S-B.
(b) New independent accountants
On August 17, 2000, the Company's Board of Directors engaged Wiss &
Company, LLP as the Company's independent accountants for the fiscal year ended
May 31, 2000.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits
16 Acknowledgement Letter from Grant Thornton LLP to the Securities and
Exchange Commission, dated August 22, 2000
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
OAK TREE MEDICAL SYSTEMS, INC.
By: /s/ Simon Boltuch
---------------------------
Name: Simon Boltuch
Title: Chief Executive Officer
Date: August 24, 2000
